Synapse
⌘+K
Synapse
PulseExploreClubsResearchersJournals
Instagram
HomeClubsExplore
September 5, 2025Open Access

Epidemiology of Levodopa-Induced Dyskinesia: Prevalence and Associated Clinical Factors in Latin America

View Full Paper
Ask AI
Bookmark
Share

Authors

HCHenry Mauricio Chaparro‐SolanoDSDaniel Teixeira dos SantosEWEmily Waldo

Discussion

Loading...

Member takes

Overview

Cross-sectional study details LID prevalence in Parkinson's patients across LATAM, highlighting varying associated factors.

Key Points

  • Overall prevalence of levodopa-induced dyskinesia was 25.4% among analyzed Parkinson's patients in LATAM.
  • LID prevalence ranged from 9.3% to 45.1% across different countries, showing significant regional variation.
  • Logistic regression analysis identified fast disease progression as a significant factor associated with LID.
  • Study emphasizes need for context-specific research, given that factors like sex had no significant impact on LID prevalence.

Cite This Study

Chaparro‐Solano et al. (2025) studied this question.

synapsesocial.com/papers/68bb3a352b87ece8dc954c55https://doi.org/10.1101/2025.08.25.25334104
View Full Paper
Ask AI
Bookmark
Share

Also Consider

Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context:

  1. 1Levodopa‐Induced Dyskinesias are Frequent and Impact Quality of Life in Parkinson's Disease: A 5‐Year Follow‐Up Study2024 · 21 citations
  2. 2Motor Complications in Parkinson's Disease: Results from 3343 Patients Followed for up to 12 Years2024 · 24 citations
  3. 3Diagnostic prediction model for levodopa-induced dyskinesia in Parkinson’s disease2020 · 15 citations
  4. 4Prevalence, distribution and future projections of Parkinson disease in Brazil: insights from the ELSI-Brazil cohort study2025 · 7 citations
  5. 5Levodopa-induced dyskinesia is still a major clinical problem in Brazilian movement disorder clinics2025 · 8 citations